InvestorsHub Logo
Followers 43
Posts 2387
Boards Moderated 0
Alias Born 08/09/2016

Re: Jamaalish post# 230587

Wednesday, 11/27/2019 3:40:47 PM

Wednesday, November 27, 2019 3:40:47 PM

Post# of 430212
Jamaal - I totally agree that the "more natural" aspect of V is a positive to the public, and probably many MDs. I just think the investment community is biased to look at "natural" as being lower in value (despite the data). I remember Pyrr using that argument, with the rebuttal being examples such as aspirin, morphine, and Taxol, all of which are natural derivatives and very effective. With so much of the trading done by retail, all you have to do is look at all of the idiotic comments on StockTwits to see the bias against a more "natural" product such as V (although I totally understand that icosapent ethyl is a manufactured molecule).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News